Ann: Trading Halt, page-173

Surely these numbers can't be right??? LOL

From the previous Partons acquisition investor presentation, the combined revenue was projected to be $21M ARR ($1.75M/month).
From the AFR article Kaddy has gross revenue of $21M ARR (also $1.75M/month)
Combined potential of 2M cases shipped per year (WD-27k/mth + PWG-60k/mth + Kaddy-83k/mth)



Total Revenue for both acquisitions puts us at $42M ARR.
With the current MC at around $120M, the capitalization is only 3x the potential revenue. This is ridiculous.
Similarly, because the SP has been hit so hard the past few weeks even trending down, there is a huge discrepancy between the SP now and the potential revenue.

The Partons acquisition diluted our SOI to around 1.9B, this Kaddy acquisition will further dilute the SOI to around 2.2B roughly ($14.75M/5.6c = an extra 263M SOI)

Conservatively if we put a multiple of 20 which was I believe during the lows = 840M MC
840M MC/2.2B SOI = 38c Share Price potentially - which is a 5-6x bagger from today

I'm sure@steve10 would have run similar numbers somewhere on this thread.

Gotta run some more numbers on potential inflexion breakeven point but I still believe it will be around late FY22/23. I would be interested in what sort of expenses amount Kaddy would have. I reckon it's similar to DW8 which will put it the operating costs at around 2.5x revenue. But still, it looks like the overall operating cost is going down when ratio'd with the revenue - I could be wrong here, but keen to see it all play out.



Go Team DT!